高级检索
当前位置: 首页 > 详情页

A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Refractory Nephrotic Syndrome

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究单位: [1]Asahi Kasei Pharma Corporation [2]Beijing Friendship Hospital, Capital Medical University,Beijing,China [3]Beijing Tongren Hospital, Capital Medical University,Beijing,China [4]China-Japan Friendship Hospital,Beijing,China [5]Chinese PLA General Hospital,Beijing,China [6]The Third Affiliated Hospital of the Third Military Medical University (Daping Hospital),Chongqing,Chongqing,China [7]Fuzhou General Hospital of Nanjing Military Region,Fuzhou,Fujian,China [8]The first Affiliated Hospital of Fujian Medical University,Fuzhou,Fujian,China [9]The First Affiliated Hospital, Sun Yat-sen University,Guangzhou,Guangdong,China [10]Affiliated Hospital of Guilin Medical University,Guilin,Guangxi,China [11]The First Affiliated Hospital of Guangxi Medical University,Nanning,Guangxi,China [12]The Third Hospital of Hebei Medical University,Shijiazhuang,Hebei,China [13]Wuxi People's Hospital,Wuxi,Jiangsu,China [14]The First Affiliated Hospital of Nanchang University,Nanchang,Jiangxi,China [15]The First Hospital of Jilin University,Changchun,Jilin,China [16]The Second Hospital of Jilin University,Changchun,Jilin,China [17]The First Affiliated Hospital of Dalian Medical University,Dalian,Liaoning,China [18]The General Hospital of Shenyang Military Region,Shenyang,Liaoning,China [19]Shandong Provincial Hospital,Jinan,Shandong,China [20]The General Hospital of Jinan Military Region,Jinan,Shandong,China [21]The Affilited Hospital of Qingdao University,Qingdao,Shandong,China [22]Renji Hospital Shanghai Jiaotong University School of Medical,Shanghai,Shanghai,China [23]Xinhua Hospital Shanghai Jiaotong University School of Medical,Shanghai,Shanghai,China [24]Zhongshan Hospital Fudan University,Shanghai,Shanghai,China [25]The Second Hospital of Shanxi Medical University,Taiyuan,Shanxi,China [26]The First Affiliated Hospital of Xi'an Jiaotong University,Xian,Shanxi,China [27]West China Hospital of Sichuan University,Chengdu,Sichuan,China [28]Kuming General Hospital of Chengdu Military Region,Kunming,Yunnan,China [29]The First Affiliated Hospital of College of Medicine, Zhejiang University,Hangzhou,Zhejiang,China

研究目的:
To demonstrate that the treatment effect in refractory nephrotic syndrome of MZR is non-inferior to that of standard therapy CTX through analyzing overall remission rate after treatment.

资源点击量:25497 今日访问量:0 总访问量:1499 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)